_db33a8.png)
.thumb.png.9594b08ba898a6b0d0fa1576ea2c9574.thumb.png.3097220ace298f0faaab6884cd0ea0f5.png)
The goal of the Mission on Cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better.
The four Cancer Mission objectives are:
- Understand;
- Prevent what is preventable;
- Optimise diagnosis and treatment;
- Support quality of life
Its five transversal priorities are:
- ensure equitable access in all aforementioned areas
- innovation
- childhood cancer
- personalised medicine
- citizen engagement
The Mission on Cancer will address all cancers including poorly-understood cancers in men and women, cancers in children, adolescents and young adults as well as in the elderly, cancers in socio-economically vulnerable populations, living in either cities, rural or remote areas, across all Member States and Associated countries.
The mission proposes research, innovation and policy directions and objectives to identify effective strategies for the development and implementation of cancer prevention, including on environmental and behavioural factors (e.g. exposure to carcinogens, air pollution, unhealthy diet, nutrition, and low physical activity).
Potential applicants may also find it helpful to watch recordings of the EU Missions Info Days on 22-23 May and register for brokerage opportunities (registration is open until 30 Sep 2025).
Horizon Europe Cluster 1: Health also includes several topics related to cancer.
UK organisations and businesses can apply for Horizon Europe funding, working as part of a three-country consortium with at least one member from within the EU (see “Who can apply?” below). If you are interested in one of the calls and would like to find a collaboration partner, contact Innovate UK Business Connect’s European Programmes team.
-
In line with Horizon Europe, all the actions supported by this call are open to actors from EU Member States and Horizon Europe Associated Countries.
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in Horizon Europe actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:
- at least one independent legal entity established in a Member State;
- and at least two other independent legal entities, each established in different Member States or Associated Countries (this includes the UK).
Our European team can help you find eligible partners to form a consortium.
There may be further eligibility conditions for specific topics. Please check the Work Programme and contact our team to ensure your eligibility before applying.
-
Potential applicants may also find it helpful to watch recordings of the EU Missions Info Days on 22-23 May and register for brokerage opportunities.
-
These are all single-stage calls with a deadline of 16 Sep 2025:
- Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational research – funding of €5m for a single project
- Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers – total funding of €30.45m, c.€6-7m per project
- Innovative surgery as the cornerstone of affordable multi-modal therapeutic interventions benefitting cancer patients with locally advanced or metastatic disease – total funding of €31m, c.€7-10m per project
- Investigator-initiated multinational early-stage innovative clinical trials for paediatric cancer – total funding of €25m, c.€6-8m per project
- Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition – total funding of €15m, c.€3-5m per project
- Support to the network of National Cancer Mission Hubs (NCMHs) – €11m for a single project
Single-stage call with deadline 4 Sep 2025:
- Increasing walking and cycling: to reap health benefits, emission reductions and integrate active mobility and micro-mobility devices, with smart technologies and infrastructure – total budget €12m, c.€6m per project. This is a joint call with the Climate-Neutral and Smart Cities Mission.
-
These funded actions will also be available as part of the Cancer Mission:
Continuation of bus roadshow with focus on cancer prevention – procurement (2025), c.€3m for a single project
Develop a monitoring system for all Mission objectives – technical assistance – procurement (2025), €0.84m for a single project
-
The following cross-cutting actions will also be funded as part of all EU Missions, opening in Dec 2025 with a closing date of 31 Mar 2026:
- Strengthening skills and capacity for the deployment of EU Missions – c.€1m for a single project
- Understanding and overcoming barriers to the scale-up of innovations supporting EU Missions – c.€2m for a single project
- Advancing lead markets and proof-of-concept for deep tech solutions contributing to EU Missions – total budget €8m, c.€4m per project
Recommended Comments
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.